Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings yield is N/A as of 2026-10-06T20:33:18.478Z.
Calculation as of: 2026-10-06T20:33:18.478Z.
Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: d5cf33dffe9efe5aedd0b9249044aa6ff6bda4d300b25a987f268f0e56c28a6c
EARNINGS YIELD
N/A
Market Cap
$1.39B
Earnings Yield
2.25%
TTM Avg
2.55%
3Y Avg
2.59%
5Y Avg
2.14%
Market Cap
$1.42B
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.37B
Earnings Yield
N/A
TTM Avg
818.17%
3Y Avg
818.17%
5Y Avg
818.17%
Market Cap
$1.45B
Earnings Yield
8.09%
TTM Avg
4.29%
3Y Avg
4.28%
5Y Avg
3.97%
| NAME | MARKET CAP | EARNINGS YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Taysha Gene Therapies, Inc. (TSHA) | $1.40B | N/A | N/A | N/A | N/A |
| Kailera Therapeutics, Inc. (KLRA)vs › | $1.40B | N/A | N/A | N/A | N/A |
| Braveheart Bio, Inc. (BRVE)vs › | $1.40B | N/A | N/A | N/A | N/A |
| AnaptysBio, Inc. (ANAB)vs › | $1.42B | 11.21% | 10.64% | 10.64% | 2.45% |
| The Pennant Group, Inc. (PNTG)vs › | $1.39B | 2.25% | 2.55% | 2.59% | 2.14% |
| Ultragenyx Pharmaceutical Inc. (RARE)vs › | $1.42B | N/A | N/A | N/A | N/A |
| Inhibrx Biosciences Inc. (INBX)vs › | $1.37B | N/A | 818.17% | 818.17% | 818.17% |
| Certara, Inc. (CERT)vs › | $1.44B | N/A | 0.64% | 0.61% | 0.61% |
| Healthcare Services Group, Inc. (HCSG)vs › | $1.45B | 8.09% | 4.29% | 4.28% | 3.97% |
| Maze Therapeutics, Inc. (MAZE)vs › | $1.46B | N/A | N/A | N/A | N/A |
Earnings Yield
N/A
EPS ÷ Price
P/E Ratio
N/A
Price ÷ EPS
Formula: Earnings Yield = (EPS / Price) × 100
Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.
How earnings yield is used:
Earnings Yield = EPS (TTM) / Share Price
Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
